Skip to Content

Join the 'Prostate Cancer' group to help and get support from people like you.

Prostate Cancer News

Related terms: Cancer, Prostate, Carcinoma of Prostate

U.S. Cancer Death Rate Declines Again, But Prostate Cancer Incidence Rises

Posted 6 hours ago by Drugs.com

TUESDAY, May 22, 2018 – There's good news for Americans in the war against cancer. Cancer deaths continue to decline nationwide, according to the Annual Report to the Nation on the Status of Cancer. But the report also points to one troubling trend – prostate cancer deaths are creeping up again after years of decline, suggesting that controversy over the best way to screen for the disease may ...

Expert Panel Highlights Patient Choice for Prostate Cancer Screen

Posted 14 days ago by Drugs.com

TUESDAY, May 8, 2018 – More men could receive PSA blood tests for prostate cancer under revised guidelines released Tuesday by the nation's leading panel on preventive medicine. The U.S. Preventive Services Task Force (USPSTF) now recommends that men aged 55 to 69 decide for themselves whether to undergo a prostate-specific antigen (PSA) test, after talking it over with their doctor. This blood ...

Could a Tattoo Someday Spot Your Cancer?

Posted 19 Apr 2018 by Drugs.com

THURSDAY, April 19, 2018 – Tattoos serve many purposes, perhaps expressing artistry, loyalty or love. Now, scientists working with mice say they've engineered a medical "tattoo" that can screen for early signs of major disease. The biomedical tattoo is made up of cells embedded with sensors that measure levels of blood calcium. It's initially invisible when implanted under the skin. But the ...

Diet, Exercise Can Ease Side Effects of Prostate Cancer Treatment

Posted 9 Apr 2018 by Drugs.com

MONDAY, April 9, 2018 – Exercise and healthy eating can counter the harmful side effects of hormone therapy for prostate cancer, a new study suggests. Androgen-deprivation therapy suppresses testosterone and other male hormones that drive prostate cancer growth. But suppressing those hormones leads to loss of muscle mass and strength as well as increased body fat, which puts patients at risk for ...

A Light Breakfast Might Cut Cost of Pricey Prostate Cancer Drug Zytiga

Posted 28 Mar 2018 by Drugs.com

WEDNESDAY, March 28, 2018 – Here's one way to cut the cost of a $10,000-a-month prostate cancer drug: Take it with food, some researchers suggest. Investigators said they found that taking Zytiga (abiraterone acetate) with a low-fat breakfast boosts its efficiency. That could make it more convenient and significantly cheaper, the new study suggested. Zytiga is the standard medicine for prostate ...

His Prostate Cancer Becomes Her Struggle, Too

Posted 24 Mar 2018 by Drugs.com

FRIDAY, March 23, 2018 – Difficulties tied to prostate cancer may not be limited to men. Many wives of men with advanced prostate cancer say their husband's illness has harmed their own health, a new study finds. "Many prostate cancer patients have a hard time, both physically and emotionally. This work shows that this stress can spill over and affect wives and partners," said Hein Van Poppel, a ...

Dad Can Pass on Ovarian Cancer Genes, Too

Posted 16 Feb 2018 by Drugs.com

FRIDAY, Feb. 16, 2018 – A gene mutation that's passed down from a father is associated with earlier onset of ovarian cancer in daughters and prostate cancer in the father and his sons, a new study suggests. Previous research had shown that sisters of women with ovarian cancer have a higher risk for the disease than their mother, but the reasons for this were unclear. "Our study may explain why ...

Dad Can Pass on Ovarian Cancer Genes, Too

Posted 16 Feb 2018 by Drugs.com

FRIDAY, Feb. 16, 2018 – A gene mutation that's passed down from a father is associated with earlier onset of ovarian cancer in daughters and prostate cancer in the father and his sons, a new study suggests. Previous research had shown that sisters of women with ovarian cancer have a higher risk for the disease than their mother, but the reasons for this were unclear. "Our study may explain why ...

New Treatment Apalutamide (Erleada) Approved for Prostate Cancer That Resists Hormone Therapy

Posted 15 Feb 2018 by Drugs.com

WEDNESDAY, Feb. 14, 2018 – Erleada (apalutamide) has been approved by the U.S. Food and Drug Administration to treat non-spreading prostate cancer that continues to grow despite hormone therapy. Prostate cancer is the second-most-common form of the disease among men in the United States, the National Cancer Institute says. More than 161,000 men were diagnosed in 2017, and nearly 27,000 men were ...

Zytiga (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer

Posted 15 Feb 2018 by Drugs.com

HORSHAM, PA, Feburary 8, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Zytiga (abiraterone acetate) in combination with prednisone for the treatment of patients with metastatic high-risk castration-sensitive prostate cancer (CSPC). The approval is based on Phase 3 data from the p ...

FDA Approves Apalutamide (Erleada) to Help Curb a Tough-to-Treat Prostate Cancer

Posted 15 Feb 2018 by Drugs.com

WEDNESDAY, Feb. 14, 2018 – A new drug that can stall the progression of a particularly hard-to-treat form of prostate cancer has been approved for use by U.S. health officials. In a recent study, the drug called Erleada (apalutamide) has shown breakthrough effectiveness in keeping prostate cancer from spreading for two years in men whose disease had not yet traveled to other parts of their body. ...

FDA Approves Erleada (apalutamide) for Non-Metastatic Castration-Resistant Prostate Cancer

Posted 14 Feb 2018 by Drugs.com

February 14, 2018 – The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer. “The FDA evaluates a v ...

What Might Make Prostate Cancer's Return More Likely?

Posted 26 Jan 2018 by Drugs.com

FRIDAY, Jan. 26, 2018 – Obesity and other health problems may boost the chances of cancer returning after a man has his prostate removed, a new study finds. "Prostate cancer is the most common cancer in men, and up to 30 percent of patients will develop recurrence after [prostate removal]," said study author Dr. Arash Samiei, of Allegheny Health Network's urology department in Pittsburgh. ...

High Costs Keep Many Cancer Patients From Needed Drugs

Posted 21 Dec 2017 by Drugs.com

THURSDAY, Dec. 21, 2017 – Cancer drugs have become so pricey that U.S. patients often can't afford them, a new study finds. The findings suggest that high out-of-pocket costs may be a barrier to potentially life-saving or life-prolonging treatments, the researchers said, and raise questions about whether patients will be able to take advantage of new cancer treatments. "Imagine leaving your ...

Insurance Ups the Odds of Beating Cancer

Posted 5 Dec 2017 by Drugs.com

TUESDAY, Dec. 5, 2017 – Your chances of surviving cancer may depend on the type of insurance you have. Researchers from the Cancer Prevention Institute of California found significant improvements in survival among cancer patients with private insurance or Medicare, but not among those who have public insurance such as Medicaid, or are uninsured. The investigators analyzed data on more than 1.1 ...

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

estradiol, Premarin, Estrace, ethinyl estradiol, Lupron Depot, Zoladex, Zytiga, Estradiol Patch, Casodex, view more... Taxotere, Eligard, Xtandi, Cenestin, capecitabine, bicalutamide, cyclophosphamide, flax, esterified estrogens, degarelix, Enjuvia, Menest, Trelstar, Vantas, Xofigo, Trelstar LA, conjugated estrogens, goserelin, Provenge, Firmagon, Sandrena, Progynova, Erleada, flutamide, radium 223 dichloride, docetaxel, leuprolide, Thais, nilutamide, Supprelin LA, Flax Seed Oil, Premarin Intravenous, sipuleucel-t, abiraterone, Jevtana, Trelstar Depot, Zoladex 3-Month, Delestrogen, Systen, histrelin, estramustine, Estratab, Docefrez, diethylstilbestrol, Stilphostrol, Thaissept, Cytadren, mitoxantrone, Provames, cabazitaxel, Emcyt, apalutamide, aminoglutethimide, Novantrone, Nilandron, enzalutamide, Viadur, Estinyl, Oromone, Eulexin, Valergen, triptorelin, Progynova TS, Zumenon, Plenaxis, Primogyn Depot, abarelix